According to NeuroPsychiatric Hospitals, suicidal thoughts and behaviors are the leading cause of disability and death in the United States. Fortunately, there are several tests available to identify suicidal thoughts. Some tests use simple questions, like the Assist Suicide-Screening Questions (ASQ), which can help identify individuals who may be at risk of suicide. Other tests, like the Columbia-Suicide Severity Rating Scale (C-SSRS), measure suicide risk by examining five key areas.
The Ask Suicide-Screening Questions Toolkit was developed by the National Institute of Mental Health. The ASQ is a brief, four-question screening instrument used to screen medical patients for suicidal ideation and behavior. It takes only 20 seconds to administer and can help identify those individuals who may be at risk of suicide. This toolkit has a wide range of uses and can be used to assess both youth and adults.
The sensitivity of the ASQ is high, indicating that it is accurate in detecting suicidal behavior. The specificity of the ASQ depends on the question combination that is used. The positive predictive value is high, indicating a child is at high risk of suicide. The negative predictive value is low, indicating that the ASQ is not as sensitive or specific as some other screening tools.
NeuroPsychiatric Hospitals pointed out that, suicide is the fourth-leading cause of death in young adults. Globally, seven hundred thousand people attempt suicide every year. This form of violence is prevalent throughout the lifespan and accounts for the fourth-leading cause of death for 15 to 29-year-olds. Early detection and prevention can reduce the incidence and impact of suicide. The C-SSRS suicidal test is a brief questionnaire designed to measure suicidal risk. Although it is not a perfect test, its accuracy and consistency make it a useful tool in clinical settings.
The C-SSRS is widely used and has been validated in various studies. It is available in three versions: the Lifetime/Recent version allows clinicians to gather information on a patient’s lifetime and recent suicidal behavior. The Since Last Visit version is a truncated version of the full version that assesses recent suicidality.
Researchers have found promising results with the K-CAT-SS, a new tool that measures depressive symptoms. The K-CAT-SS is sensitive and specific enough to detect youth who have suicidal thoughts, but it also helps determine whether an intervention will prevent the emergence of suicidal thoughts. The research team hopes to use the CAT-SS in other settings and examine whether other factors influence the results.
The program uses self-report questionnaires to identify at-risk youth and support universal screenings in emergency departments. The youth are then called three months after the initial screening to discuss suicide risk factors. The results of the research will help improve school policies. In addition to helping prevent suicide, the program can help educate emergency department staff and clinicians about youth suicide. The K-CAT-SS will help prevent suicide in youth by ensuring that youth receive proper care.
NeuroPsychiatric Hospitals described that, in collaborative assessment of suicidality (CAMS), the patient and therapist collaborate to identify and understand each other’s underlying motives and experiences. The clinical tools of CAMS include the Suicide Status Form and are developed collaboratively between the patient and clinician. The patient’s input is an essential component of the CAMS clinical process, which is a collaborative endeavor that can include a variety of treatment modalities.
During the suicidal assessment, CAMS clinicians strive to understand the patient’s pain from an empathetic and nonjudgmental perspective. A CAMS clinician strives to understand each patient’s pain from a non-judgmental, intra-subjective perspective. This helps them formulate treatment plans that are tailored to the individual’s needs.